Search Results
Jul 17, 2026, 09:00 ET Superteam Wheels Launches Ultra SL SE All-Scenario Wheelset with DT180 Hubs
significant improvements in actual riding, enabling all-scenario adaptation.Q4: Why choose DT180 hubs?A4: There are many excellent hubs, and we chose DT180 hubs because of their outstanding performance and limited development in the international market. Matching
More news about: Superteam Wheels
Jul 17, 2026, 08:50 ET Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
it.Definium Therapeutics, Inc. (NASDAQ: DFTX), formerly Mind Medicine, carries the deepest late-stage pipeline in the group. Lead candidate DT120 ODT, an orally disintegrating tablet of lysergide tartrate previously known as MM120, is in five Phase 3 studies spanning generalized anxiety disorder,
More news about: USA News Group
Jul 16, 2026, 03:39 ET xTool O1 Omni Printer Hits the Global Market, Empowering Businesses and Creators with Industrial-Grade "Print Anything" Versatility
Single UV Edition: $1,699 Early-Bird Price / $2,499 MSRPThe Dual UV Edition: $2,699 Early-Bird Price / $3,299 MSRPThe UV + DT Fabric Edition: $2,799 Early-Bird Price / $3,499 MSRPCustomers who previously placed their pre-order deposits can now complete their
More news about: xTool
Jul 06, 2026, 10:31 ET Fuchs Endothelial Corneal Dystrophy Market Forecast Highlights Significant Growth During the Forecast Period (2026-2036), Owing to the Expanding Treatment Landscape and Increasing Patient Pool | DelveInsight
emerging therapies such as Ripasudil (K-321) (Kowa Pharmaceuticals), TTHX1114 (Trefoil Therapeutics), STN1010904/AE-001 (sirolimus) (Santen/ActualEyes), DT-168 (Design Therapeutics), and others will further propel the market growth.LAS VEGAS, July
More news about: DelveInsight Business Research, LLP
Jul 02, 2026, 08:00 ET SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
transform vaccine R&D and further enhancing AI-based data analytics and decision-making capabilities as part of its broader digital transformation (DT) strategy.About SK bioscience SK bioscience is
More news about: SK bioscience
Jun 30, 2026, 21:14 ET ZTE-CDO Cui Li auf dem MWC Shanghai 2026: Wertschöpfung und Ungewissheit im Zeitalter der KI
Development Officer des Unternehmens, auf dem MWC Shanghai 2026 eine Keynote mit dem Titel „Unlocking Value and Embracing Uncertainty in the AI Era" (dt. Wertschöpfung und Ungewissheit im Zeitalter der KI) gehalten hat.
More news about: ZTE Corporation
Jun 26, 2026, 09:30 ET A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
from its Phase 3 Emerge study of DT120 (lysergide) orally disintegrating tablet in MDD: the study met its primary endpoint with a placebo-adjusted MADRS reduction of 8.1 points at week 6 (p<0.0001) and, the company reported, met all key secondary endpoints, with DT120 generally well tolerated and no
More news about: USA News Group
Jun 24, 2026, 08:55 ET NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
results.Opening BellRoads to Success celebrates 25 years of impactClosing BellDT Midstream (NYSE: DTM) celebrates 5 years as a public companyFor market insights, IPO activity, and today's opening bell, download the NYSE
More news about: New York Stock Exchange
Jun 23, 2026, 09:50 ET Category-Defining Sex Toy "Groove Thing" Now Available to Order, After Record Kickstarter
https://www.instagram.com/reels/DT3w2ioAQVR/
More news about: Groove Thing
Jun 16, 2026, 07:04 ET Affle Announces Strategic Acquisition of AdColony Technology Assets and Trademark from DT
Acquisition Strengthens Affle 3i Consumer Platform Tech Stack and Reinforces Commitment to Accelerated Growth with Ongoing Commercial Partnership with DTSAN FRANCISCO and GURUGRAM, India, June 16, 2026 /PRNewswire/ --
More news about: Affle
Jun 15, 2026, 22:48 ET UROVO DT610 Pro: The Rugged AI Terminal Redefining Frontline Productivity
global leader in enterprise mobility solutions, unveiled the DT610 Pro, a next-generation ultra-rugged intelligent terminal purpose-built to empower frontline operations across industries. Designed to withstand the toughest environments, DT610 Pro combines enterprise-grade durability with cutting-edge
More news about: UROVO
Jun 15, 2026, 11:00 ET Affle Announces Strategic Acquisition of AdColony Technology Assets and Trademark from DT
Acquisition Strengthens Affle 3i Consumer Platform Tech Stack and Reinforces Commitment to Accelerated Growth with an Ongoing Commercial Partnership with DT.SAN FRANCISCO, June 15, 2026 /PRNewswire/ --
More news about: Affle
Jun 04, 2026, 10:01 ET Generalized Anxiety Disorder Market Forecast Shows Strong CAGR During the Forecast Period (2026-2036) Driven by Innovative Therapies | DelveInsight
include DT120 ODT (LSD D-Tartrate) (Definium Therapeutics), Ulotaront (SEP-363856) (Sumitomo Pharma/Otsuka), HLP004 (Helus Pharma), ITI-1284 (Intra-Cellular Therapies, Inc.), ABBV-932 (AbbVie), and others.Definium Therapeutics' DT120 orally disintegrating
More news about: DelveInsight Business Research, LLP
Jun 04, 2026, 07:45 ET Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia
StudyNichols DA, Schneider LD, Plante DT, Dai J, Steininger TL, Whalen M, Cairns A, Ruoff CM, Van Dongen HPA
More news about: Jazz Pharmaceuticals plc
Jun 03, 2026, 18:01 ET Congreso ERA: Semaglutida vinculada a una mejor calidad de vida en la diabetes y la enfermedad renal, muestra EL ENSAYO FLOW
muestran que la semaglutida una vez por semana mejoró significativamente la calidad de vida relacionada con la salud en adultos con diabetes tipo 2 (DT2) y enfermedad renal crónica (ERC), lo que equivale a alrededor de ocho días adicionales de salud completa por año. El ensayo demostró previamente
More news about: ERA Congress
Jun 03, 2026, 18:01 ET Congrès de l'ERA : L'essai FLOW montre que le sémaglutide est associé à une meilleure qualité de vie dans le diabète et les maladies rénales
semaglutide administré une fois par semaine améliore significativement la qualité de vie liée à la santé chez les adultes atteints de diabète de type 2 (DT2) et d'insuffisance rénale chronique (IRC), ce qui équivaut à environ huit jours supplémentaires en pleine santé par an. L'étude a déjà démontré
More news about: ERA Congress
Jun 02, 2026, 08:03 ET DT Introduces Launchpad, a Unified Platform for Modern App Distribution
toward a more connected mobile ecosystem. Powered by DT iQ and Ignite Graph, DT connects signals across devices and apps to support more intelligent, personalized, and performance-driven distribution across the mobile ecosystem.About DTDT (NASDAQ: APPS) is unifying the mobile ecosystem
More news about: Digital Turbine, Inc.
Jun 01, 2026, 07:00 ET Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies
domain with diphtheria toxin (DT) fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the DT fragment is cleaved and the free DT fragments inhibit protein synthesis,
More news about: Citius Oncology, Inc.
May 26, 2026, 08:00 ET Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting
domain with diphtheria toxin (DT) fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the DT fragment is cleaved and the free DT fragments inhibit protein synthesis,
More news about: Citius Oncology, Inc.
May 21, 2026, 09:53 ET Digital Turbine Expands AI Capabilities Across Its Mobile Platform Through Deepened Google Cloud Partnership
of the industry's richest mobile signal environments through its Ignite Graph and DT iQ intelligence layer. By combining those proprietary signals with Gemini Enterprise Agent Platform and Google Cloud infrastructure, DT is embedding AI directly into the core intelligence systems powering its platform
More news about: Digital Turbine, Inc.
May 20, 2026, 03:52 ET Strauss Group Reports Q1-2026 Financial Results:¹ Strong start of 2026 with Revenues of NIS 3.0 billion, EBIT of NIS 316 million with EBIT margin of 10.5%, and Net Profit of NIS 181 million
link: https://us02web.zoom.us/webinar/register/WN_GQrgHkv_RT6dt0UUse-_pw Webinar ID: 865 5444 7992Questions for the questions and answers session may be submitted (up to 2
More news about: Strauss Group Ltd.
May 19, 2026, 15:14 ET BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in psoriatic arthritis: BE BOLD Week 16 data
from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study. Ann Rheum Dis. 2023 Nov;82(11):1404-1414.Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, et al. American College of Rheumatology.
More news about: UCB
May 19, 2026, 11:10 ET Digital Turbine and Orange Partner to Redefine App Distribution in Europe
advertisers, app owners, and device partners through on-device integrations, direct app partnerships, and intelligence powered by the Ignite Graph and DT iQ - turning rich data into actionable insight and measurable performance while delivering the scale and performance of a walled garden without the walls.
More news about: Digital Turbine, Inc.
May 19, 2026, 08:45 ET Digital First Operations Infrastructure Spending Continues, Accelerating Across Every Major Industry
Ignite Graph, which maps real-time device interactions to drive predictive modeling and actionable insights, and DT iQ, which aggregates data for smarter targeting. To accelerate these outcomes, DT will leverage Genie, Databricks' AI agent that lets any employee chat with their data and get trusted answers.
More news about: Market News Updates
May 14, 2026, 05:00 ET NOVOSENSE Expands SafeNovo® Portfolio for Automotive Functional Safety Applications
helping improve switching robustness, localized sensing and safety integration in SiC and IGBT-based systems operating under high-frequency and high-dv/dt conditions.Beyond powertrain, NOVOSENSE functional safety solutions support a broad range of automotive applications. The ASIL B NSUC1800
More news about: NOVOSENSE